With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, August 12, 2025 approved the following: 1). ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd's Board of Directors met on Tuesday, August 12, 2025, and approved the Standalone Un-Audited Financial Results for the quarter ended June 30, 2025, in compliance with SEBI LODR Regulation 33. The meeting was brief, lasting only 15 minutes (6:30 PM to 6:45 PM). No specific financial figures, such as revenue, profit, or margins, are disclosed in this filing; those would be in the attached results document. The disclosure was made to BSE under Regulation 30 read with Schedule III(A)(IV) of the SEBI LODR Regulations, 2015.
This is a routine regulatory disclosure confirming the board's approval of Q1 FY26 results. Without actual numbers in this filing, there is no immediate direct impact on shareholders; investors should look at the attached financial results for any meaningful data on the company's performance.